
Milnacipran Film-Coated Tablets Suppliers & Bulk Manufacturers
Available Forms: Film-coated Tablets
Available Strengths: Film-coated Tablets
Reference Brands: Savella(US); Ixel®, Toledomin(EU)
Category: Antipsychotropic Drugs
Milnacipran Film-coated Tablets is available in Film-coated Tablets and strengths such as Film-coated Tablets. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Milnacipran Film-coated Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Milnacipran Film-coated Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: In the United States, milnacipran film-coated tablets are FDA-approved primarily for the management of fibromyalgia, not for depression, although it's classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). Regulatory requirements include boxed warnings for increased suicidal risk in young adults, GMP compliance, and post-marketing surveillance. Manufacturers must provide evidence of bioavailability, long-term safety, and labeling accuracy. In the European Union, milnacipran is approved under various national procedures for the treatment of major depressive disorder (MDD), with less emphasis on fibromyalgia. EU regulations mandate a Risk Management Plan (RMP), pharmacovigilance systems, and Periodic Safety Update Reports (PSURs). For dossier-ready supply and partnerships, visit Pharmatradz.com.
Frequently Asked Questions
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View DetailsZuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View DetailsZuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsZuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers